CAR T-cell therapy is a treatment that takes T-cells from your blood, changes them in a lab, and then puts them back in your body. T-cells are immune system cells that can be changed in a lab so that they attack cancer cells. Your T-cells are changed so that they have a special receptor on them that binds to certain proteins on cancer cells. This receptor is called chimeric antigen receptor, or CAR. These CAR T-cells are grown in a lab and then infused (given through a needle) back into your body to attack cancer cells.
Neurotoxicity is damage to your brain and nervous system. Neurotoxicity can be caused by toxins like:
The signs and symptoms you have depend on the cause of your neurotoxicity. Signs and symptoms can happen right away or can happen years later. Every person’s experience with neurotoxicity is different.
Neurotoxicity can be a side effect of CAR T-cell therapy. There are still a lot of unknowns about how CAR T-cell therapy causes neurotoxicity and why only some people are affected by it. This is because it is a newer treatment and research is ongoing. Some symptoms of neurotoxicity related to CAR T-cell therapy are:
Symptoms vary from person to person and can range from mild to severe.
There is no specific treatment for neurotoxicity caused by CAR T-cell therapy. Your symptoms will be managed using medication and other therapies. In most cases, your neurotoxicity symptoms will go away within 3-8 weeks. Corticosteroids, which decrease inflammation, can be used to decrease swelling in your brain. However, treatment with high doses of corticosteroids can affect how your T-cells work. Your provider will decide what course of treatment is right for you.
Any changes in how you think, walk, talk, or have new or worsening headaches are always a reason to contact your provider. If you have recently been treated with CAR T-cell therapy and you have any new symptoms related to neurotoxicity, contact your provider right away.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania